VistaGen Therapeutics
1998
FOUNDED
PUBLIC
STATUS
1-10
EMPLOYEES
VTGN
STOCK SYMBOL
1
INVESTMENTS
$1.04
SHARE PRICE
(As of Friday Closing)
Description
VistaGen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Its lead product candidate, AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of a major depressive disorder in patients with an inadequate response to standard antidepressants.
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
- 343 Allerton Avenue
- South San Francisco, CA 94080
- United States
+1 (650) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore VistaGen Therapeutics’s full profile, request a free trial.
VistaGen Therapeutics Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $0.38 - $2.44 | $44.3M | $1.10 | -$0.84 | 270K | 42.6M |
VistaGen Therapeutics Financials Summary
|
In Thousands,
USD |
TTM
30-Jun-2019
|
FY 2019
31-Mar-2019
|
FY 2018
31-Mar-2018
|
FY 2017
31-Mar-2017
|
|---|---|---|---|---|
| Enterprise Value | 17,893 | 46,412 | 8,280 | 13,972 |
| Revenue | 0 | 0 | 0 | 1,250 |
| EBITDA | (26,491) | (24,488) | (14,254) | (10,194) |
| Net Income | (26,585) | (24,590) | (14,346) | (10,256) |
| Total Assets | 12,947 | 14,012 | 11,278 | 3,712 |
| Total Debt | 4,490 | 67 | 66 | 69 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
VistaGen Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore VistaGen Therapeutics‘s full profile, request access.
Request full access to PitchBookVistaGen Therapeutics Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 00000000 | 11-May-2011 | 000000000000000000 | Other Consumer Products and Services | 00000 00000 00 |
VistaGen Therapeutics Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore VistaGen Therapeutics‘s full profile, request access.
Request full access to PitchBookVistaGen Therapeutics Executive Team (7)
You’re viewing 5 of 7 executives. Get the full list »VistaGen Therapeutics Board Members (3)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 00000 000000000 00.0 | VistaGen Therapeutics | Director | 000 0000 | |
| 0000 0000 00 | Self | Chairman | 000 0000 | |
| 00000 00000 00 | VistaGen Therapeutics | Chief Executive Officer & Board Member | 000 0000 |